Stocks in Focus on June 15: Coal India, Shyam Metalics, JSW Ispat, Clariant Chemicals to Pharma Stocks; here are the 5 Newsmakers of the Day

The Sensex and the Nifty on Monday, June 14, 2021, logged marginal gains to hit record highs. The S&P BSE Sensex climbed 77 points, or 0.15 per cent, to finish at 52,552. The Nifty 50 also added 13 points, or 0.08 per cent, to close at 15,812. But certain stocks came in the news after the market was closed. These stocks can impact the indices, when it reopens Tuesday, June 15, 2021. List of such five stocks:

See Zee Business Live TV Streaming Below:

Coal India + Satin Creditcare + JB Chemicals + IFB Industries 

Coal India: The state-owned coal mining company has reported a YoY consolidated profit of Rs 4,589 crore for the quarter ended March 31, 2021. It had posted a profit of Rs 4,626 crore in the corresponding quarter of the last financial year. Consolidated revenue from operations declined 3% to Rs 26,700 crore in the reported quarter compared to Rs 27,568 crore posted last year. EBITDA stood at Rs 6,382 crore in the period under consideration compared to R 6,389 crore posted last year. The margin remained almost flat at 23.9% in Q4FY21 compared to 23.17% posted in Q4FY20. In addition, the FSA realizations grew 3% QoQ to Rs 1,392 crore compared to Rs 1,354 crore. E-auction realizations grew 20% QoQ to Rs 1,752 crore compared to Rs 1,466 crore. Trade receivables grew 36% YoY to Rs 19,623 compared to Rs 14,408 crore. Besides, the board has recommended a final dividend of Rs 3.50 crore for FY21. 
Satin Creditcare: The microfinance institution Satin Creditcare Network Limited has reported a 192% YoY rise in the profit at Rs 38 crore for the quarter ended March 31, 2021. It had posted a profit of Rs 13 crore in the corresponding quarter of the previous financial year. The Net Interest Income (NII) fell 10% YoY to Rs 243 crore compared to Rs 270 crore posted last year. Net interest margin fell to 12.3% in Q4FY21 against 14% posted in Q4FY20. The micro lender’s gross NPA stood at 8.4% in Q4FY21 compared to 9.6% posted in Q3FY21. The net NPA stood at 3.3%. AUM stood at Rs 8,379 crore compared to Rs 7,880 crore posted in the previous quarter. Disbursement grew 6.5% QoQ to Rs 2,376 crore compared to Rs 2,231 crore posted last year. Collection efficiency improved to 105% in Q4FY21 compared to 98% posted in Q4FY20. The lender has said that the business is approaching pre-COVID levels. 
JB Chemicals & Pharmaceuticals: The pharmaceutical company has reported two times YoY jump in the consolidated profit at Rs 101 crore for the quarter ended March 31, 2021. It had posted a profit of Rs 50 crore in the corresponding quarter of the previous financial year. The consolidated revenue from operations grew 19% to Rs 528 crore compared to Rs 443 crore posted last year. The EBITDA grew 35% to Rs 124 crore compared to Rs 92 crore posted last year. Segment-wise, the domestic formulations business grew 9%, while the international business grew 31%. The margin improved to 23.5% in Q4FY21 compared to 21% posted in Q4FY20. The board has recommended a final dividend of Rs 8 per share. 
IFB Industries: The company has reported a profit of Rs 7.71 crore for the quarter ended March 31, 2021. It had posted a loss of Rs 20 crore in the corresponding quarter of the previous financial year. The revenue from operations grew 63% YoY to Rs 825 crore compared to Rs 507 crore posted last year. The EBITDA stood at Rs 54 crore compared to Rs 0.8 crore posted last year. The margins stood at 6.5%. 

IPO Update + JSW Ispat OFS 

Shyam Metalics: The initial public offering (IPO) of Shyam Metalics & Energy was subscribed 1.23 times on the first day of subscription. The retail portion was subscribed 2.19 times, while the NII and employee portion were subscribed 0.70 times and 0.27 times, respectively. Shyam Metalics seeks to raise up to Rs 909 crore through the issue. The price band of the issue has been fixed at Rs 303-306 per share. The subscription will close on June 16, 2021.
Sona Comstar: The initial public offering of auto component marker Sona BLW Precision Forgings (Sona Constar) was subscribed 11% on the first day of subscription. The retail portion was subscribed 0.51 times, while the QIB and NII portion was subscribed 0.02 times and 0.01 times, respectively. The company seeks to raise up to Rs 5,550 crore the issue. The price band of the issue has been fixed at Rs 285-291 per share. The subscription will close on June 16, 2021.
JSW Ispat Special Products Ltd: Promoter AION Investments Private II Limited proposes to sell up to 9.94 crore shares, representing 21.18% stakes, to raise up to Rs 268.55 crore. The floor price for the sale shall be Rs 27 per equity share. The OFS will open today for the non-retail investors and will open for retail investors tomorrow. 10% of the offer shares will be reserved for retail investors. 

Clariant Chemicals: The global holding Company, Clariant AG has announced that it has reached definitive agreements for the divestment of its Pigments Business to a consortium of Heubach Group and SK Capital Partners at an Enterprise Value (EV) of CHF 805 million to CHF 855 million (Rs 6547 crore -Rs 6954 crore) on a cash and debt-free basis. At the time of closing of the transaction, Clariant will reinvest to become a 20% shareholder alongside Heubach and SK Capital in the ultimate holding company. Clariant said the sale, which is expected to be completed in the first half of 2022. Besides, Luxembourg Investment Company has made an open offer for the acquisition of up to 60 lakhs equity shares (representing 26% stakes) for a total consideration of Rs 280 crore. The offer price has been fixed at Rs 466.84 per share.  

Strides Pharma Science + Pharma Stocks 

Strides Pharma: Announced that its step‐down wholly-owned subsidiary, Strides Pharma Global Pte. Limited, Singapore has entered into an exclusive partnership with Ennaid Therapeutics, a global pharmaceutical company to produce an oral, repurposed medication to treat mild, moderate and asymptomatic cases of COVID‐19. Ennaid is ready to seek emergency authorization from the FDA in the United States as well as approval for compassionate use in India. Strides will be the exclusive manufacturing partner to Ennaid for the product.
Dr Reddy/Cipla/Zydus Cadila/Jubilant Life: The Union Government on Monday revised the export policy of Remdesivir injection and Remdesivir Active Pharmaceutical Ingredients (API). Now, Remdesivir has been shifted to 'restricted category' from ‘prohibited category’. With this, the export of Remdesivir injection/API against the advance authorization will not require separate authorization permission. 

Bulk Deals 

Zensar Technologies Ltd 

DSP Mutual Fund bought 67.56 lakh shares at 294.74/share. 

Goldman Sachs bought 25.75 lakh at 294.98/share. 

Nippon India MF bought 41.5 lakh Shares at 294.95/share. 

Marina Holdco sold 2.57 crore shares at 295.16/share. 

Va Tech Wabag 

Equity Intelligence India & Eq Fund Sold 1.23% Stake in Company on 10th June. 

Holding Decreased from 1.87% to 0.64%.